NO302525B1 - 17-spirofuran-3'-yliden-steroider - Google Patents

17-spirofuran-3'-yliden-steroider Download PDF

Info

Publication number
NO302525B1
NO302525B1 NO924857A NO924857A NO302525B1 NO 302525 B1 NO302525 B1 NO 302525B1 NO 924857 A NO924857 A NO 924857A NO 924857 A NO924857 A NO 924857A NO 302525 B1 NO302525 B1 NO 302525B1
Authority
NO
Norway
Prior art keywords
hydrogen
lower alkyl
spirofuran
ylidene
mixture
Prior art date
Application number
NO924857A
Other languages
English (en)
Norwegian (no)
Other versions
NO924857D0 (no
NO924857L (no
Inventor
Johannes Antonius Mar Hamersma
Everardus Otto Maria Orlemans
Johannes Bernardus Ma Rewinkel
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of NO924857D0 publication Critical patent/NO924857D0/no
Publication of NO924857L publication Critical patent/NO924857L/no
Publication of NO302525B1 publication Critical patent/NO302525B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
NO924857A 1991-12-20 1992-12-15 17-spirofuran-3'-yliden-steroider NO302525B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91203366 1991-12-20

Publications (3)

Publication Number Publication Date
NO924857D0 NO924857D0 (no) 1992-12-15
NO924857L NO924857L (no) 1993-06-21
NO302525B1 true NO302525B1 (no) 1998-03-16

Family

ID=8208088

Family Applications (1)

Application Number Title Priority Date Filing Date
NO924857A NO302525B1 (no) 1991-12-20 1992-12-15 17-spirofuran-3'-yliden-steroider

Country Status (16)

Country Link
US (1) US5292878A (fr)
EP (1) EP0549041B1 (fr)
JP (1) JP3462515B2 (fr)
KR (1) KR100287513B1 (fr)
AT (1) ATE128983T1 (fr)
AU (1) AU655858B2 (fr)
CA (1) CA2084431C (fr)
DE (1) DE69205405T2 (fr)
DK (1) DK0549041T3 (fr)
ES (1) ES2081040T3 (fr)
FI (1) FI104178B1 (fr)
GR (1) GR3018630T3 (fr)
MX (1) MX9207394A (fr)
NO (1) NO302525B1 (fr)
NZ (1) NZ245520A (fr)
ZA (1) ZA929315B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2100514C (fr) * 1992-07-29 2005-03-29 Johannes A. M. Hamersma Steroides de type 17-spiromethylene
TR200001334T2 (tr) * 1997-11-14 2000-09-21 Akzo Nobel N.V. Progestojen-anti-progestojen rejimleri.
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
AU4093799A (en) 1998-05-22 1999-12-13 Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
US6262042B1 (en) * 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US5962444A (en) * 1998-05-29 1999-10-05 Research Triangle Institute 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
SK15502001A3 (sk) * 1999-04-29 2002-03-05 Akzo Nobel N. V. Použitie Org 33245
US6043235A (en) * 1999-07-21 2000-03-28 Research Triangle Institute 11β-aryl-17, 17-spirothiolane-substituted steroids
US7426602B2 (en) * 2004-01-08 2008-09-16 Topside Research, Llc Switch for bus optimization
TW200531977A (en) 2004-03-25 2005-10-01 Akzo Nobel Nv Progesterone receptor modulators
CA2789262C (fr) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Systeme pharma-informatique
EP1945240B1 (fr) 2005-09-16 2016-12-28 Raptor Pharmaceutical Inc Compositions de proteines rap specifiques des proteines contenant du cr, et leurs utilisations
ATE453660T1 (de) * 2006-02-17 2010-01-15 Janssen Pharmaceutica Nv 17-phosphor-steroid-derivate als progesteron- rezeptormodulatoren
WO2007098381A2 (fr) * 2006-02-17 2007-08-30 Janssen Pharmaceutica N.V. Dérivés stéroïdiens 11-phosphoreux utilisés comme modulateurs du récepteur de la progestérone
AU2007327707B2 (en) 2006-10-24 2012-07-12 Allergan pharmaceuticals International Ltd. Compositions and methods for suppressing endometrial proliferation
TWI539953B (zh) 2008-04-28 2016-07-01 瑞波若斯治療學公司 用於治療乳癌之組成物和方法
TR201908314T4 (tr) 2009-02-20 2019-06-21 2 Bbb Medicines B V Glutatyon bazlı ilaç dağıtım sistemi.
US8673968B2 (en) * 2009-04-06 2014-03-18 Evestra, Inc. Progesterone antagonists
KR101909711B1 (ko) 2009-05-06 2018-12-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
CN101926806A (zh) * 2009-06-24 2010-12-29 天津金耀集团有限公司 一种17磷类雌甾化合物在制备紧急避孕药物中的应用
CN107260745A (zh) 2010-03-22 2017-10-20 利普生物药剂公司 用于抗孕酮的非毒性递送的组合物和方法
WO2011157443A1 (fr) 2010-06-17 2011-12-22 N.V. Organon (11b,17a)-11-(4-(2-11c-acetyl)phenyl)-17,23-epoxy-19,24-dinorchola-4,9,20-trien-3-one
US9096641B2 (en) 2013-06-05 2015-08-04 Evestra, Inc. Imidazolyl progesterone antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0116974B1 (fr) * 1983-02-18 1986-10-29 Schering Aktiengesellschaft 11-Bêta-aryl-estradiènes, procédé de préparation et compositions pharmaceutiques les contenant
FR2596395B1 (fr) * 1986-03-26 1989-05-26 Roussel Uclaf Nouveaux steroides comportant un cycle spirannique en position 17, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
DE3761308D1 (de) * 1986-07-23 1990-02-08 Akzo Nv 18-phenylestrane-derivate.
IE60780B1 (en) * 1987-01-23 1994-08-10 Akzo Nv New 11-aryl steroid derivatives
EP0289073B1 (fr) * 1987-04-24 1991-11-27 Akzo N.V. Dérivés de 11-arylestranes et 11-arylprégnanes
ES2053714T3 (es) * 1987-12-12 1994-08-01 Akzo Nv Proceso para la preparacion de 11-arilesteroides.

Also Published As

Publication number Publication date
NO924857D0 (no) 1992-12-15
CA2084431C (fr) 2003-04-08
JP3462515B2 (ja) 2003-11-05
US5292878A (en) 1994-03-08
FI104178B (fi) 1999-11-30
EP0549041A1 (fr) 1993-06-30
NZ245520A (en) 1995-02-24
MX9207394A (es) 1993-07-30
DK0549041T3 (da) 1996-01-29
FI104178B1 (fi) 1999-11-30
CA2084431A1 (fr) 1993-06-21
EP0549041B1 (fr) 1995-10-11
NO924857L (no) 1993-06-21
ATE128983T1 (de) 1995-10-15
FI925790L (fi) 1993-06-21
HK1002033A1 (en) 1998-07-24
AU3009392A (en) 1993-06-24
JPH05255380A (ja) 1993-10-05
DE69205405T2 (de) 1996-05-09
AU655858B2 (en) 1995-01-12
FI925790A0 (fi) 1992-12-18
KR100287513B1 (ko) 2001-05-02
ES2081040T3 (es) 1996-02-16
GR3018630T3 (en) 1996-04-30
DE69205405D1 (de) 1995-11-16
ZA929315B (en) 1993-05-24

Similar Documents

Publication Publication Date Title
NO302525B1 (no) 17-spirofuran-3'-yliden-steroider
FI81588C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 11 -fenyl-17-hydroxi-4,9(10)-estradien-3-oner.
AU682195B2 (en) New 11-benzaldoxime-estradiene-derivatives, methods for their production and pharmaceuticals containing these substances
KR100445376B1 (ko) 11-(치환된페닐)-에스트라-4,9-디엔유도체
FI85377B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 13-alkyl-11 -fenylgonaner.
FI89054C (fi) Nya 11-arylsteroidderivat
JP2652007B2 (ja) 位置１７にスピロ環を有する新規なステロイドの製造用中間体
KR100341169B1 (ko) 17-스피로메틸렌스테로이드
US5728689A (en) 11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
RU2152952C2 (ru) Производные 11,21-бисфенил-19-норпрегнана, способ их получения, фармацевтическая композиция и способ ее получения
RU2187510C2 (ru) Производные 16-гидрокси-11-(замещенный фенил)-эстра-4,9-диена, соединение, фармацевтическая композиция
HU196224B (en) Process for production of 19-nor or 19-nor-d-homo stereoids substituated in position 11-beta by alkinylphenil group and medical preparatives containing them as active substance
IE892141L (en) 13-alkyl-11ß-phenylgonanes
JP5731498B2 (ja) １７−ヒドロキシ−１７−ペンタフルオロエチルエステル−４，９（１０）−ジエン１１−エチニルフェニル誘導体、その製造方法、及び疾病の治療のためのその使用
US5232915A (en) 9α-hydroxy-19,11β-bridged steroids, their production and pharmaceutical preparations containing these steroids
Faraj et al. Synthesis of new steroidal 11β-substituted spirolactones
JPH08502276A (ja) ゲスターゲン作用を有する１９，１１−架橋した４−エストレン
HU201091B (en) Process for producing gonatriene derivatives and pharmaceutical compositions comprising same
HK1002033B (en) 17-spirofuran-3'-ylidene steroids
MXPA96003476A (es) Derivados de 11-(fenilo sustituido)-estra-4,9-dieno